We are live on ! Find out more
OIMU

Orbis Investment Management (US) Portfolio holdings

AUM $99.7M
1-Year Est. Return 17.51%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
-17.51%
3 Year Est. Return
+48.85%
5 Year Est. Return
+64.6%
10 Year Est. Return
–
AUM
$119M
AUM Growth
+$3.15M
Cap. Flow
+$4.14M
Cap. Flow %
3.48%
Top 10 Hldgs %
63.41%
Holding
26
New
4
Increased
3
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.56M
2
ELV icon
Elevance Health
ELV
+$3.45M
3
HUM icon
Humana
HUM
+$3.33M
4
AGN
Allergan plc
AGN
+$2.73M
5
BHI
Baker Hughes
BHI
+$2.51M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.46M
2
AAPL icon
Apple
AAPL
+$3.11M
3
MSFT icon
Microsoft
MSFT
+$2.22M
4
AMGN icon
Amgen
AMGN
+$2.08M
5
CLH icon
Clean Harbors
CLH
+$886K

Sector Composition

Rank Sector Weight
1 Healthcare 23.62%
2 Financials 18.56%
3 Technology 17.79%
4 Industrials 16.35%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
26
Microsoft
MSFT
$3.75T
– –
-40,187
Closed -$2.22M
1
2

Similar funds

BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
DCM
Diag Capital Management New York $87.4M AUM
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
CFA
Clarfeld Financial Advisors Tarrytown, New York $120M AUM
BPV
Battery Partners VIII Boston, Massachusetts $121M AUM 101.35% 1-Year Est. Return

Orbis Investment Management (US)'s Q2 2016 Portfolio in Review

As of Q2 2016, Orbis Investment Management (US) held 26 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Orbis Investment Management (US) deployed $4.14M of net new capital in Q2 2016, opening 4 new positions and adding to 3 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 38,911 shares worth $5.63M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Merck, an estimated $5.46M trimmed.

  • Orbis Investment Management (US)'s largest Q2 2016 buy was Berkshire Hathaway Class B: 38,911 shares worth $5.63M.
  • Orbis Investment Management (US) added most to Elevance Health in Q2 2016, an estimated $3.45M increase.
  • Orbis Investment Management (US)'s biggest Q2 2016 reduction was Merck, cutting an estimated $5.46M.
  • Orbis Investment Management (US) fully exited Apple in Q2 2016, selling an estimated $3.11M.
  • Orbis Investment Management (US)'s ten largest holdings make up 63% of its $119M portfolio in Q2 2016.
  • Orbis Investment Management (US) opened 4 new positions and closed 3 in Q2 2016.
  • Orbis Investment Management (US)'s portfolio value rose 2.7% quarter-over-quarter to $119M.

Based on Orbis Investment Management (US)'s 13F filing for Q2 2016, filed 15 Aug 2016.